“Hemolytic Uremic Syndrome” Presented by: Elizabeth Talley, MD Clinical Professor - Pediatric Nephrology Stanford Medicine Children’s Health Planners expect learners to: 1. Define Hemolytic Uremic Syndrome (HUS). 2. Explain the pathogenesis of HUS and how that informs treatment. 3. Describe available treatment options for HUS. UCSF Benioff Children’s Hospital Oakland is accredited by the California Medical Association to provide continuing medical education for physicians. UCSF Benioff Children’s Hospital Oakland designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.ABP MOC Part 2 PointsSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. Contact Cristina.Fernandez@ucsf.edu for further details.ABS Continuous Certification (CC)Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn 1 credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. Contact Cristina.Fernandez@ucsf.edu for further details.Zoom Participants:Please contact Cristina.Fernandez@ucsf.edu for webinar information. For CME credit, evaluations must be completed by 12pm on the Friday after Grand Rounds. Requests for the link to the current evaluation must be sent to Cristina.Fernandez@ucsf.edu by NOON on the day of Grand Rounds.Dr. Talley has no relevant financial relationships with ineligible companies to disclose. As planning peers without relationships with ineligible companies, Michelle Nakaishi, CPNP and RE Morrell, MD reviewed Dr. Kittams financial relationship with Merck and Pfizer; Dr. Kevin Yen's financial relationship with Biomarin Pharmaceutical, Eli Lily & Co. and Eton Pharmaceuticals, and Dr. Venturelli's financial relationship with Moderna and found that these relationships were not relevant to this presentation. The following planners for this educational activity do not have relevant financial relationships to disclose: Sabina Ali, MD; Allison Coleman, MD; Javay Ross MD; Prachi Singh, DO. Did you miss Grand Rounds? Visit http://vimeo.com/album/2238536 and use password CHRCO to view recorded Grand Rounds presentations. For CME recordings of UCSF/BCH faculty, please visit https://medconnection.ucsfbenioffchildrens.org/cme